Company News: Johnson & Johnson (JNJ) quarterly earnings beat analysts’ estimate

Noticias del mercado

16 julio 2019

Company News: Johnson & Johnson (JNJ) quarterly earnings beat analysts’ estimate

Johnson & Johnson (JNJ) reported Q2 FY 2019 earnings of $2.58 per share (versus $2.10 in Q2 FY 2018), beating analysts’ consensus of $2.44.

The company’s quarterly revenues amounted to $20.562 bln (-1.3% y/y), generally in line with analysts’ consensus estimate of $20.388 bln.

The company also announced it continued to see FY 2019 EPS of $8.53-8.63 (versus analysts’ consensus estimate of $8.62) but raised FY 2019 revenues guidance to $80.8-81.6 bln from prior $80.4-81.2 bln (versus analysts’ consensus estimate of $81.27 bln).

JNJ rose to $135.95 (+0.92%) in pre-market trading.

UK wage growth hits fresh post-crisis high - ING

RBA's minutes provide no indication of cutting rates again in the near term - TDS

Enfoque del mercado

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Abrir cuenta demo y página personal

Área personal

support@teletradepartners.com

Aviso de riesgo: El hecho de realizar operaciones comerciales en los mercados financieros con instrumentos financieros de margen abre grandes oportunidades y permite a los inversores que estén dispuestos a correr riesgos a obtener altos rendimientos, pero al mismo tiempo conlleva un nivel de riesgo de pérdidas potencialmente alto. Por lo tanto, antes de comenzar a operar, se debe tomar de manera responsable a la cuestión de elegir una estrategia de inversión correspondiente, teniendo en cuenta los recursos disponibles.

Política de privacidad